GLP-1 Drops UK: What They Are and Whether They Work (October 2026)

01 · The core answer

Are GLP-1 drops worth using?

No licensed prescription GLP-1 medicine that we supply comes as drops, so drops are not a like-for-like substitute for a prescribed treatment. The licensed medicines with published trial results are once-weekly injection pens or once-daily tablets, not drops. Mounjaro, for example, is described in its product information as a pre-filled multi-dose pen.¹ A bottle of drops carrying a similar-sounding name has not been shown to do the same job.

The phrase is also used loosely. Some sellers use it for plant-based supplements, some for sublingual liquids, and some for products that claim to contain tirzepatide or semaglutide. These are very different things, and a label does not tell you which one you are buying. That is the heart of the problem: you cannot check what is in the bottle, how strong it is, or whether it has been made to a pharmaceutical standard.

If your goal is weight management, the decision is really between three paths: a licensed prescription medicine, an NHS service where you qualify, or lifestyle support on its own. Drops are not a fourth path with the same evidence behind it.

Our guide on whether drops are safe goes through the individual concerns in more detail.

02 · Your next step

What should you do next?

Decide first whether you meet the licensed criteria, because that determines your options. Mounjaro is licensed for adults with a BMI of 30 or above, or a BMI between 27 and 30 with at least one weight-related condition, and it must be used alongside a reduced-calorie diet and increased physical activity.¹ A prescriber assesses your BMI, medical history and current medicines before deciding whether it is suitable.

If you meet those criteria, a regulated route is open to you. Our weight loss clinic starts with a free online consultation, reviewed by a GPhC-registered prescriber. The Mounjaro pen starter dose costs £129.99 for a new customer's first 2.5mg pen with code FIRST40 (standard price £169.99). Every later order is £25 off the standard price. Prices checked 10 October 2026.

If you do not meet the criteria, or a prescriber advises against treatment, that is a useful answer too. It is far better than buying an unverified liquid and hoping it behaves like a medicine. Whatever you choose, tell a pharmacist or prescriber about anything you are already taking, including supplements, so interactions can be considered.

03 · What drops claim to be

What are GLP-1 drops?

GLP-1 drops are a marketing term, not a medical category. Some are botanical supplements promoted as 'natural GLP-1' boosters. Some are sublingual liquids that claim to deliver a pharmaceutical ingredient under the tongue. Others borrow the name of a prescription medicine, such as tirzepatide, to suggest an equivalence that has not been shown.

The licensed GLP-1 treatments are a different thing entirely. Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes, and it comes as a pre-filled multi-dose pen.¹ It is not licensed as a drop, a spray or a tablet, so a product described as 'tirzepatide drops' is not the licensed medicine.

That matters because every figure people quote about GLP-1 treatments comes from trials of the licensed medicines in their licensed forms. A trial of an injected medicine cannot be borrowed to describe a different liquid made by a different seller. The ingredient, its strength, how it is absorbed and how it was manufactured all affect what a product does.

Why the name spreads

The term spreads because it is easy to remember and sounds gentle. Wording such as 'natural', 'sublingual' or 'oral liquid' makes a product sound closer to a pharmacy medicine than it is. Phrases like 'how to take GLP-1 oral liquid' presuppose a standard way of taking it, but there is no standard because there is no single product. You may see claims about how to use drops or follow published directions; these are the seller's instructions, not directions from a licensed product leaflet.

What a real medicine label looks like

A licensed medicine has a named active ingredient, a defined strength, a product information leaflet, a batch number, a licence holder and a regulator behind it. Mounjaro KwikPens have a patient information leaflet that explains use and side effects.¹³ If a product cannot show you those things, you cannot know what you are taking.

Our pharmacy is registered with the GPhC (9012878), and you can check the register yourself. That is the standard to apply to any seller: can you verify who they are, what they are supplying and who reviewed your suitability?

04 · How GLP-1 medicines work

What do GLP-1 medicines actually do?

GLP-1 medicines act on gut-hormone receptors that help regulate appetite and how the body handles food. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1.¹ Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.

In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet. That last part is important. The medicine is a support for eating less and moving more, not a replacement for either. This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).

If a product were a true licensed GLP-1 medicine, it would act on these receptors. But a bottle of drops sold without a prescription has not been shown to reach those receptors in a meaningful way. When a seller says their liquid 'boosts GLP-1 naturally', that is a claim about a general effect, not evidence that the product works like a pharmaceutical agonist.

Why slower stomach emptying matters

Slower stomach emptying is part of why people feel full for longer. It is also why some side effects, such as nausea or a heavy feeling after eating, are common when starting a GLP-1 medicine. A prescriber supports you through those early weeks and adjusts the plan with you. Products sold as drops come with no such oversight, so a person who feels unwell has nobody who knows what they took.

Mounjaro is injection-only

There is no tablet form of Mounjaro — tirzepatide is injection-only in the UK. The licensed Mounjaro pen delivers a measured dose in a controlled way, in a set strength from 2.5mg up to 15mg.

How long it stays in the body

Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹ This is useful context if you ever stop treatment or switch products: a prescriber can advise you on timing. An unlabelled liquid gives you no such information.

Dosing charts that circulate for drops do not map onto licensed titration.

05 · What the evidence shows

Do GLP-1 drops really work?

The published figures belong to the injectable pens. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.²

A worked example, not a promise

For someone starting at 100 kg, 20.9% is about 21 kg. That is straight arithmetic of the trial average at the highest dose, and it does not predict your own result. It also describes an injected medicine used for a long period with diet and activity changes. It says nothing about drops.

Why borrowed numbers mislead

Sellers of drops sometimes place trial figures near their products, or describe them as 'GLP-1 support'. The implication is that the numbers apply. They do not. A trial result belongs to the medicine, dose and form that was studied. If a product has not been studied, the honest position is that its effect is unknown.

Reviews are not evidence

Reviews tell you what someone believed, not what a product contained or did. Weight changes for many reasons, including simply paying more attention to food.

What 'work' should mean

For a medicine, 'works' should mean a measured result in a defined group of people, compared with a control, using a verified product. By that standard the injectable pens have an evidence base and drops do not. Within the first few weeks of any approach, most people notice only small changes, and that is normal. Do not read an early change as proof that a product is doing something special.

If you want a result that is backed by published research, the licensed route is the one with the data. It is also the one with a prescriber who can tell you honestly whether treatment is right for you.

06 · Safety and side effects

Are GLP-1 drops safe, and what are the side effects?

Nobody can give a reliable safety answer for drops as a category, because the contents differ and are not verified. Safety information exists for the licensed medicines, and it comes from their product information, not from sellers. Our guide to the side effects people ask about sets this out at more length.

For a licensed medicine, the picture is documented. Mounjaro is not suitable for everyone. You should not take it if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive.¹ Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. Always share your full medical history and medicine list during consultation.

In rodent studies tirzepatide caused thyroid C-cell tumours; it is not known whether this applies to humans, and no increase has been shown in human trials. As a precaution, tell your prescriber if you or a close relative have had medullary thyroid cancer or the inherited condition MEN 2 — they will weigh this in your assessment. Routine thyroid monitoring is not required for most people.¹

That kind of screening is exactly what you lose when you buy a liquid with no consultation: nobody asks about your history, your family history or the medicines you already take. Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing.

Contraception and other medicines

Prescribers also review interactions as part of an assessment. If you use oral contraception, the medicine can reduce absorption of oral contraceptives because stomach emptying slows, and your prescriber will advise you on this. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ If you take insulin or sulfonylureas, doses may need adjusting because of the risk of low blood sugar. These are not things a seller of drops will check with you.

Reporting problems

If you feel unwell after any product, seek advice from a pharmacist or doctor and tell them exactly what you took, including the bottle. You can also report suspected side effects through the MHRA Yellow Card scheme.¹⁹ Keep the packaging so the product can be identified.

A symptom that is not on the patient leaflet list is not a listed side effect. Discuss any new symptom with your prescriber rather than assuming it is normal. Like all medicines, Mounjaro can cause side effects, and most are digestive: the most common — affecting more than 1 in 10 people — are nausea, diarrhoea, vomiting, constipation and abdominal discomfort.¹³

07 · Spotting misleading claims

How can you spot misleading drop claims?

Look for what a seller cannot show you: a named regulator, a registered pharmacy, a prescriber review and a product leaflet. Where those are missing, treat the marketing with caution. The MHRA publishes guidance and counterfeit medicine alerts, and runs the Yellow Card scheme for reporting suspected problems.⁷

Warning signs

• Dramatic weight-loss claims with no mention of diet, activity or individual variation.
• 'Natural GLP-1' wording that implies a plant product behaves like a prescription medicine.
• No consultation: anyone offering to supply a GLP-1 product without a consultation or prescription.
• Borrowed brand names, such as 'tirzepatide drops', when the licensed medicine is a pen.
• Dosing charts for a liquid that mimic licensed titration, with no product leaflet behind them.
• No pharmacy registration that you can look up yourself.

On that last point, you can check any UK pharmacy on the GPhC public register. Ours is registration 9012878.

Why 'natural' is not a safety statement

The word 'natural' describes where something comes from, not whether it is safe or effective. Plenty of natural substances cause harm, and plenty interact with prescribed medicines. Low-cost supplements are available cheaply without assessment, which is part of their appeal, but it also means nobody has checked whether they are suitable for you. Supplement dosing is not standardised, so two bottles with the same name may differ.

The same name, a different product

A common trick is to pair a recognisable medicine name with a bottle of liquid. The licensed Mounjaro is supplied direct from Eli Lilly's UK distribution; we source ours via official LillyDirect supply, and all doses are in stock. A seller using the same words without that supply chain is not offering the same thing.

If you suspect a fake

Do not use it. Keep the packaging and report it through the Yellow Card scheme, which also accepts reports of suspected counterfeit or falsified medicines.⁷ A pharmacist can talk through what to do next. If you have taken something and feel unwell, seek advice from a pharmacist or doctor and say what you took. If you have severe, persistent stomach pain, swelling of the face or throat, or difficulty breathing, get medical help straight away.

Our page on the prescription question explains why a product that is sold without one should make you ask more questions, not fewer.

08 · Licensed eligibility

Who can take a licensed GLP-1 medicine?

Adults who meet the licensed criteria and pass a prescriber's review can take one. Mounjaro is licensed for weight management in adults with a BMI of 30 or above, or a BMI between 27 and 30 with at least one weight-related condition such as high blood pressure, high cholesterol, obstructive sleep apnoea, cardiovascular disease, prediabetes or type 2 diabetes.¹ It must be used alongside a reduced-calorie diet and increased physical activity.

A prescriber will assess your BMI, medical history and current medicines before deciding whether it is suitable for you. That assessment is the safety step that drops skip altogether.

Ethnic background and BMI

People from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds are at higher risk of weight-related health problems at a lower BMI, so clinical thresholds are usually reduced by 2.5 kg/m² for these groups. If this applies to you, mention it in your consultation, because it can change which route is open to you.

Who should not take it

Allergy to tirzepatide or its ingredients, and pregnancy or trying to conceive, rule treatment out. A history of pancreatitis, severe gut or digestive disease, diabetic retinopathy or gallbladder problems calls for extra care or a recommendation against treatment.

Belly fat and the first week

People often ask whether they will lose belly fat, or whether they will lose weight in the first week. Trial results are averages over 72 weeks, so expect treatment to be a gradual process, and expect the early weeks to be about settling in and managing side effects rather than dramatic change. Be wary of any product that promises specific results in a short time.

Diet and activity still matter

Treatment sits alongside a reduced-calorie diet and increased physical activity. Our prescribing team supports that through monthly reviews, dose-titration and follow-up assessments, with side-effect support throughout. That ongoing relationship is the thing a bottle of drops cannot offer.

If you are unsure whether you qualify, the free consultation at our weight loss clinic is no-charge and no-obligation.

09 · NHS and private options

Can you get a GLP-1 on the NHS?

Yes, but access is phased. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

If you are curious about NHS eligibility, your GP is the first person to ask. NHS access to Wegovy runs through specialist weight-management services; ask your GP.

Why people go private

Some people meet the licensed criteria but not the earliest NHS groups. They face a wait, and some choose a regulated private route. The point is that the route should still be regulated. A UK online pharmacy such as ours is registered with the GPhC, supplies the licensed pen and has every prescription reviewed by a GPhC-registered prescriber.

What private treatment involves

You complete a short online health questionnaire. A prescriber reviews it, and if they decide treatment is not suitable, the order is refunded automatically in full. The pharmacy dispenses and dispatches the order. Delivery is free next-day tracked delivery in temperature-controlled, discreet packaging, with Saturday delivery at £14.99.

Comparing the licensed medicines

Mounjaro is not the only licensed choice. You can view the Wegovy pen if you want to compare. Liraglutide, including Saxenda, is supplied at 6mg/ml and is a daily injection, unlike once-weekly Mounjaro and Wegovy.

A prescriber can talk you through which, if any, suits you. The choice depends on your history, preferences and what you have tolerated before, not on a product's marketing.

Whichever route you choose, the common thread is oversight: someone qualified has looked at your health, and the product you receive is the one that was prescribed.

10 · Cost and ordering

What does a regulated GLP-1 cost and how do you order?

Your first 2.5mg Mounjaro pen costs £129.99 with code FIRST40 (standard price £169.99). Prices checked 10 October 2026. If you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices; a new customer's first order is £40 less and every later order £25 less. The Mounjaro pen page shows live prices for each strength.

A first year costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg, again before discounts. For other maintenance doses, the monthly price is £279.99 at 7.5mg, £290.99 at 10mg and £319.99 at 12.5mg.

Why cost matters here

Drops are often sold on the idea that they are a cheaper, simpler alternative. A low outlay for something with no evidence behind it is not good value, because the question is whether it does anything. A regulated treatment has a price you can see, and the consultation is free: the price shown is the price paid, with no hidden fees. Payment is by Visa or Mastercard, Klarna or pay-monthly options, and there are no subscriptions.

How ordering works

• Free online consultation: a short health questionnaire, no charge, no obligation.
• Prescriber review: reviewed by a GPhC-registered prescriber, not a scoring script. Unsuitable orders are refunded automatically.
• Dispensing and dispatch: from our registered pharmacy, with same-day dispatch when ordered by 3pm.
• Delivery: free next-day tracked delivery, with needles, sharps bin and injection guidance included in every order.

Aftercare and support

Ongoing monthly reviews, dose-titration and follow-up assessments are part of treatment, with side-effect support from the prescribing team. Repeat orders re-check suitability, and nothing ships automatically. Support runs Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, account portal chat or phone on 0333 207 0413. The free GLPTrackr app helps you track your journey on iOS and Android.

This is what a regulated supply looks like, and it is the practical contrast with drops. When you have a question about a product, you can reach someone who knows what you were prescribed.

11 · If you already bought drops

What if you have already bought drops?

Stop using them if you feel unwell, and speak to a pharmacist or your GP, taking the bottle with you. You are not alone: many people try these products out of curiosity or frustration with slow progress. The aim now is to keep yourself safe and decide your next step calmly.

Before you do anything else

Check the packaging for a named active ingredient, a manufacturer, a batch number and a product leaflet. If these are missing or vague, you cannot know what you took. Write down the product name, the seller and when you started. That helps a clinician advise you and helps if you report a problem.

Telling a clinician

Mention everything you take, including supplements. Some supplements can affect how other medicines work, and a prescriber needs the full picture before starting or continuing treatment. Be honest, since nobody will judge you; the goal is accurate advice. If you later start a licensed medicine, your prescriber will need to know what else you have used.

Reporting

If you had a reaction, you can report it through the MHRA Yellow Card scheme, even if you are not sure the product caused it.¹⁹ Reports help regulators spot patterns.

Moving to something with evidence

If your reason for trying drops was weight management, consider whether you meet the licensed criteria. If you do, a free consultation costs nothing and carries no obligation, and a prescriber will tell you honestly whether treatment is suitable. If you do not meet the criteria, or treatment is not suitable, speak to your GP or pharmacist about support that fits your situation, including dietary and activity help.

Setting expectations

Whichever route you take, treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them. Individual results vary, and trial averages do not predict your own result. A sensible plan has a regular review, an honest conversation about progress and a clinician you can ask. Our weight loss clinic offers exactly that structure, with £40 off a new customer's first order using code FIRST40 and an automatic £25 reorder discount on every future order (code DOSE25).

You can review our prescription explainer and the pages on dosing and directions to understand why a clinician-led route differs so much from a bottle of drops.